Alector, Inc. Common Stock vs. Krystal Biotech, Inc. Common Stock
ALEC
Alector, Inc. Common Stock
$2.34 -2.09%
VS KRYSKrystal Biotech, Inc. Common Stock
$351.46 -1.68%
Krystal Biotech, Inc. Common Stock (KRYS) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ALEC | KRYS | |
|---|---|---|
| Market Cap | $261.28 million | $10.40 billion |
| Revenue (TTM) | $13.86 million | $440.48 million |
| Net Income (TTM) | $-117,854,000 | $241.47 million |
KRYS leads on 3 of 3 size & scale factors.
Valuation
| ALEC | KRYS | |
|---|---|---|
| P/E Ratio | — | 44.04 |
| Price / Book | -26.21 | 7.65 |
| Price / Sales | 18.85 | 23.62 |
ALEC leads on 2 of 2 valuation factors.
Profitability
| ALEC | KRYS | |
|---|---|---|
| Net Margin | -850.13% | 54.82% |
| Return on Equity | 1182.09% | 17.77% |
ALEC and KRYS split the profitability factors evenly.
Risk & Sentiment
| ALEC | KRYS | |
|---|---|---|
| Short Interest | 0.58% | 0.11% |
KRYS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ALEC overview, ALEC financials, KRYS overview, KRYS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.